Bernie Sanders is sharpening his barbs toward Democrats who have resisted his and President Joe Biden's agenda.
The Senate Budget chair railed against moderate opposition to a prescription drug overhaul that top Democrats want to include in Biden’s massive social spending package, arguing that centrists rejecting the measures are bankrolled and beholden to the pharmaceutical industry. It was the kind of riposte he'd refrained from making for weeks as a handful of House and Senate moderates refused to support the party's $3.5 trillion spending blueprint.
“Take a hard look at those people who are opposed to strong legislation to lower the cost of prescription drugs and take a look at their campaign finance reports,” Sanders (I-Vt.) said during a briefing with reporters. “See where they get their money, how many of them get their money from the pharmaceutical industry and the executives there. And I think there will be a direct correlation.“
The Vermont Independent’s comments come after Sen. Kyrsten Sinema (D-Ariz.), a key Senate centrist, told the White House that she‘s opposed to the drug pricing proposals drafted by House Democrats, which could raise hundreds of billions of dollars to help finance Biden‘s party-line bill. A number of House moderates — most of whom have received substantial donations from the pharmaceutical industry and represent districts where drug companies employ thousands of people — also say they’re concerned about the bill’s impact on the development of new cures and therapies, echoing arguments the industry itself is pushing in ad campaigns.
【 在 hugo745 (归途无期) 的大作中提到: 】 : Bernie Sanders is sharpening his barbs toward Democrats who have resisted : his and President Joe Biden's agenda. : : The Senate Budget chair railed against moderate opposition to a prescription : drug overhaul that top Democrats want to include in Biden’s massive social : spending package, arguing that centrists rejecting the measures are : bankrolled and beholden to the pharmaceutical industry. It was the kind of : riposte he'd refrained from making for weeks as a handful of House and : Senate moderates refused to support the party's $3.5 trillion spending : blueprint. : : “Take a hard look at those people who are opposed to strong legislation to : lower the cost of prescription drugs and take a look at their campaign : finance reports,” Sanders (I-Vt.) said during a briefing with reporters. “ : See where they get their money, how many of them get their money from the : pharmaceutical industry and the executives there. And I think there will be : a direct correlation.“ : : The Vermont Independent’s comments come after Sen. Kyrsten Sinema (D-Ariz.) : , a key Senate centrist, told the White House that she‘s opposed to the : drug pricing proposals drafted by House Democrats, which could raise : hundreds of billions of dollars to help finance Biden‘s party-line bill. A : number of House moderates — most of whom have received substantial : donations from the pharmaceutical industry and represent districts where : drug companies employ thousands of people — also say they’re concerned : about the bill’s impact on the development of new cures and therapies, : echoing arguments the industry itself is pushing in ad campaigns.
Bernie Sanders is sharpening his barbs toward Democrats who have resisted
his and President Joe Biden's agenda.
The Senate Budget chair railed against moderate opposition to a prescription drug overhaul that top Democrats want to include in Biden’s massive social spending package, arguing that centrists rejecting the measures are
bankrolled and beholden to the pharmaceutical industry. It was the kind of
riposte he'd refrained from making for weeks as a handful of House and
Senate moderates refused to support the party's $3.5 trillion spending
blueprint.
“Take a hard look at those people who are opposed to strong legislation to lower the cost of prescription drugs and take a look at their campaign
finance reports,” Sanders (I-Vt.) said during a briefing with reporters. “See where they get their money, how many of them get their money from the
pharmaceutical industry and the executives there. And I think there will be a direct correlation.“
The Vermont Independent’s comments come after Sen. Kyrsten Sinema (D-Ariz.), a key Senate centrist, told the White House that she‘s opposed to the
drug pricing proposals drafted by House Democrats, which could raise
hundreds of billions of dollars to help finance Biden‘s party-line bill. A number of House moderates — most of whom have received substantial
donations from the pharmaceutical industry and represent districts where
drug companies employ thousands of people — also say they’re concerned
about the bill’s impact on the development of new cures and therapies,
echoing arguments the industry itself is pushing in ad campaigns.
不错个屁，左叉哪个不是满嘴仁义道德，买肚子男盗女娼
钱 哪里来，这是个大傻叉！！
【 在 hugo745 (归途无期) 的大作中提到: 】
: Bernie Sanders is sharpening his barbs toward Democrats who have resisted : his and President Joe Biden's agenda.
:
: The Senate Budget chair railed against moderate opposition to a
prescription
: drug overhaul that top Democrats want to include in Biden’s massive
social
: spending package, arguing that centrists rejecting the measures are
: bankrolled and beholden to the pharmaceutical industry. It was the kind of
: riposte he'd refrained from making for weeks as a handful of House and
: Senate moderates refused to support the party's $3.5 trillion spending
: blueprint.
:
: “Take a hard look at those people who are opposed to strong legislation
to
: lower the cost of prescription drugs and take a look at their campaign
: finance reports,” Sanders (I-Vt.) said during a briefing with reporters. “
: See where they get their money, how many of them get their money from the : pharmaceutical industry and the executives there. And I think there will
be
: a direct correlation.“
:
: The Vermont Independent’s comments come after Sen. Kyrsten Sinema (D-Ariz.)
: , a key Senate centrist, told the White House that she‘s opposed to the
: drug pricing proposals drafted by House Democrats, which could raise
: hundreds of billions of dollars to help finance Biden‘s party-line bill. A
: number of House moderates — most of whom have received substantial
: donations from the pharmaceutical industry and represent districts where
: drug companies employ thousands of people — also say they’re concerned
: about the bill’s impact on the development of new cures and therapies,
: echoing arguments the industry itself is pushing in ad campaigns.